Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
0.4270
+0.0045 (1.07%)
At close: Jun 9, 2026, 4:00 PM EDT
0.4185
-0.0085 (-1.99%)
Pre-market: Jun 10, 2026, 7:40 AM EDT
Soligenix Market Cap
Soligenix has a market cap or net worth of $4.4 million as of June 10, 2026. Its market cap has decreased by -26.66% in one year.
Market Cap
4.40M
Enterprise Value
-1.30M
1-Year Change
-26.66%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since December 1, 1998, Soligenix's market cap has decreased from $24.80M to $4.40M, a decrease of -82.26%. That is a compound annual growth rate of -6.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 6.30M | -53.33% |
| Dec 31, 2025 | 13.50M | 98.53% |
| Dec 31, 2024 | 6.80M | -13.92% |
| Dec 29, 2023 | 7.90M | -59.49% |
| Dec 30, 2022 | 19.50M | -31.10% |
| Dec 31, 2021 | 28.30M | -25.92% |
| Dec 31, 2020 | 38.20M | 27.76% |
| Dec 31, 2019 | 29.90M | 96.71% |
| Dec 31, 2018 | 15.20M | -21.65% |
| Dec 29, 2017 | 19.40M | 128.24% |
| Dec 30, 2016 | 8.50M | -72.40% |
| Dec 31, 2015 | 30.80M | 42.59% |
| Dec 31, 2014 | 21.60M | -37.39% |
| Dec 31, 2013 | 34.50M | 414.93% |
| Dec 31, 2012 | 6.70M | 1.52% |
| Dec 30, 2011 | 6.60M | -83.90% |
| Dec 31, 2010 | 41.00M | -11.64% |
| Dec 31, 2009 | 46.40M | 660.66% |
| Dec 31, 2008 | 6.10M | -62.11% |
| Dec 31, 2007 | 16.10M | -2.42% |
| Dec 29, 2006 | 16.50M | 20.44% |
| Dec 30, 2005 | 13.70M | -49.07% |
| Dec 31, 2004 | 26.90M | -0.37% |
| Dec 31, 2003 | 27.00M | 167.33% |
| Dec 31, 2002 | 10.10M | -22.90% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 5.35M |
| TransCode Therapeutics | 5.32M |
| Mustang Bio | 5.08M |
| Matinas BioPharma Holdings | 5.05M |
| Pulmatrix | 4.86M |
| GeoVax Labs | 4.77M |
| Dermata Therapeutics | 4.75M |
| Galmed Pharmaceuticals | 4.58M |